Stockreport

OcuSciences Welcomes Michael Patane, PhD, to its Board of Directors [Yahoo! Finance]

Kiora Pharmaceuticals, Inc.  (KPRX) 
PDF assessing retinal metabolic activity, today announced the addition of Michael Patane, PhD, to its Board of Directors. Dr. Patane brings over 25 years of drug discovery a [Read more]